Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Sponsor: Immunovant Sciences GmbH
Summary
This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.
Official title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2025-06-19
Completion Date
2027-05
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
IMVT-1402
Dose 1 for 26 weeks
IMVT-1402
Dose 2 for 26 weeks
Placebo
For 26 weeks
Locations (116)
Site Number - 1015
Tucson, Arizona, United States
Site Number -1014
Concord, California, United States
Site Number - 1013
Aurora, Colorado, United States
Site Number - 1024
Doral, Florida, United States
Site Number - 1008
Hialeah, Florida, United States
Site Number - 1000
Miami, Florida, United States
Site Number - 1020
Columbus, Georgia, United States
Site Number - 1022
Topeka, Kansas, United States
Site Number - 1030
Louisville, Kentucky, United States
Site Number - 1033
Jefferson City, Missouri, United States
Site Number - 1004
Kansas City, Missouri, United States
Site Number - 1019
St Louis, Missouri, United States
Site Number - 1012
Reno, Nevada, United States
Site Number - 1032
Long Island City, New York, United States
Site Number - 1027
New Hyde Park, New York, United States
Site Number - 1009
New York, New York, United States
Site Number - 1018
Williamsville, New York, United States
Site Number - 1010
Chapel Hill, North Carolina, United States
Site Number - 1026
Hickory, North Carolina, United States
Site Number - 1001
Morehead City, North Carolina, United States
Site Number - 1034
Raleigh, North Carolina, United States
Site Number - 1007
Oklahoma City, Oklahoma, United States
Site Number - 1017
Memphis, Tennessee, United States
Site Number - 1029
Dallas, Texas, United States
Site Number - 1002
El Paso, Texas, United States
Site Number - 1003
Fort Worth, Texas, United States
Site Number - 1031
Houston, Texas, United States
Site Number - 1028
Houston, Texas, United States
Site Number -1023
Irving, Texas, United States
Site Number - 1021
Irving, Texas, United States
Site Number - 1025
McKinney, Texas, United States
Site Number - 1011
San Antonio, Texas, United States
Site Number - 1016
Norfolk, Virginia, United States
Site Number - 5105
Sydney, New South Wales, Australia
Site Number - 5103
Warrawong, New South Wales, Australia
Site Number - 5101
Brisbane, Queensland, Australia
Site Number - 5100
Southport, Queensland, Australia
Site Number - 5102
Box Hill, Victoria, Australia
Site Number - 5104
Geelong, Victoria, Australia
Site Number - 5108
Perth, Australia
Site Number - 5109
Saint Leonards, Australia
Site Number - 5610
Sofia, Sofia-Grad, Bulgaria
Site Number - 5613
Dobrich, Bulgaria
Site Number - 5606
Plovdiv, Bulgaria
Site Number - 5607
Plovdiv, Bulgaria
Site Number - 5601
Sliven, Bulgaria
Site Number - 5612
Smolyan, Bulgaria
Site Number - 5604
Sofia, Bulgaria
Site Number - 5609
Sofia, Bulgaria
Site Number - 5608
Sofia, Bulgaria
Site Number- 5605
Sofia, Bulgaria
Site Number - 5602
Varna, Bulgaria
Site Number - 5603
Varna, Bulgaria
Site Number - 5611
Varna, Bulgaria
Site Number - 5600
Yambol, Bulgaria
Site Number - 3203
Náchod, Czechia
Site Number - 3201
Prague, Czechia
Site Number - 3200
Prague, Czechia
Site Number - 3202
Prague, Czechia
Site Number - 8004
Imereti, Georgia
Site Number - 8003
Tbilisi, Georgia
Site Number - 8000
Tbilisi, Georgia
Site Number - 8002
Tbilisi, Georgia
Site Number - 8001
Tbilisi, Georgia
Site Number - 8005
Tbilisi, Georgia
Site Number - 3902
Athens, Greece
Site Number - 3900
Athens, Greece
Site Number - 3901
Athens, Greece
Site Number - 4202
Ramat Gan, Central District, Israel
Site Number - 4205
Haifa, Haifa District, Israel
Site Number - 4203
Haifa, Haifa District, Israel
Site Number - 4209
Nahariya, Northern District, Israel
Site Number - 4206
Tzfat, Northern District, Israel
Site Number - 4211
Beersheba, Southern District, Israel
Site Number - 4201
Jerusalem, Israel
Site Number - 4204
Jerusalem, Israel
Site Number - 4210
Kfar Saba, Israel
Site Number - 4200
Petah Tikva, Israel
Site Number - 4208
Rehovot, Israel
Site Number - 4207
Tel Aviv, Israel
Site Number - 6003
Milan, Italy
Site Number - 6001
Rome, Italy
Site Number - 6002
Udine, Italy
Site Number - 4600
Ogre, Latvia
Site Number - 4602
Riga, Latvia
Site Number - 4603
Riga, Latvia
Site Number - 4604
Sigulda, Latvia
Site Number - 4601
Ventspils, Latvia
Site Number - 2003
Rotterdam, South Holland, Netherlands
Site Number - 2200
Rotterdam, South Holland, Netherlands
Site Number - 2201
Rotterdam, South Holland, Netherlands
Site Number - 2202
Zwijndrecht, South Holland, Netherlands
Site Number - 3301
Auckland, New Zealand
Site Number - 3300
Wellington, New Zealand
Site Number - 3004
Bialystok, Podlaskie Voivodeship, Poland
Site Number - 3001
Szczecin, West Pomeranian Voivodeship, Poland
Site Number - 3002
Bydgoszcz, Poland
Site Number - 3010
Chorzów, Poland
Site Number - 3007
Kielce, Poland
Site Number - 3000
Lublin, Poland
Site Number - 3005
Olsztyn, Poland
Site Number - 3009
Opole, Poland
Site Number - 3006
Poznan, Poland
Site Number - 3008
Warsaw, Poland
Site Nnumber - 3003
Wroclaw, Poland
Site Number - 4500
Daegu, South Korea
Site Number - 4503
Goyang, South Korea
Site Number - 4504
Guri-si, South Korea
Site Number - 4501
Seoul, South Korea
Site Number - 4506
Seoul, South Korea
Site Number - 4505
Seoul, South Korea
Site Number - 7009
Cornwell, United Kingdom
Site Number - 7006
London, United Kingdom
Site Number - 7001
London, United Kingdom
Site Number - 7010
Salford, United Kingdom
Site Number - 7008
Surrey, United Kingdom